Key result
Surgical versus medical management for acute ischemic mitral regurgitation has not been evaluated in any published randomized controlled trials, resulting in an empty systematic review.
Why the study?
Does mitral valve surgery improve short-term and long-term mortality compared to medical management alone in patients with acute ischemic mitral regurgitation?
Systematic Review
Does mitral valve surgery improve short-term and long-term mortality compared to medical management alone in patients with acute ischemic mitral regurgitation?
There is a complete lack of randomized controlled trial evidence to guide the choice between surgical and medical management for acute ischemic mitral regurgitation, highlighting a critical knowledge gap.
No takes yet. Share an insight, caveat, or question.
No RCT evidence guides surgical versus medical management of acute ischemic mitral regurgitation; leaves open the optimal strategy and requires prospective trials.
Alajaji et al. (2015) conducted a systematic review in Acute ischemic mitral regurgitation. Mitral valve surgery vs. Medical management alone was evaluated on Short-term and long-term mortality. Surgical versus medical management for acute ischemic mitral regurgitation has not been evaluated in any published randomized controlled trials, resulting in an empty systematic review.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: